calendar
23,492 catalysts · 5,000 device 510k · 4,728 grant · 3,928 approval · 3,045 8k filing · 2,000 device pma · 2,000 device recall
next 91 dayslessmore
MonWedFri
23,492 catalysts · 5,000 device 510k · 4,728 grant · 3,928 approval · 3,045 8k filing · 2,000 device pma · 2,000 device recall
Sponsor: TAKEDA PHARMS USA. Form: INJECTABLE. Route: INJECTION
Sponsor: TAKEDA PHARMS USA. Form: INJECTABLE. Route: INJECTION
Sponsor: TAKEDA PHARMS USA. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: TAKEDA PHARMS USA. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: GRANULES. Form: TABLET. Route: ORAL
Sponsor: GRANULES. Form: TABLET. Route: ORAL
Sponsor: PH HEALTH. Form: SOLUTION. Route: ORAL
Sponsor: VIIV HLTHCARE. Form: TABLET. Route: ORAL
Sponsor: VIIV HLTHCARE. Form: TABLET. Route: ORAL
Sponsor: VIIV HLTHCARE. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: VIIV HLTHCARE. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: VIIV HLTHCARE. Form: TABLET. Route: ORAL
Sponsor: VIIV HLTHCARE. Form: TABLET. Route: ORAL
Sponsor: SCIENTURE. Form: SPRAY. Route: NASAL
Sponsor: ENDO OPERATIONS. Form: TABLET. Route: ORAL
Sponsor: PROTEGA PHARMS. Form: TABLET. Route: ORAL
Sponsor: INDIVIOR. Form: SOLUTION, EXTENDED RELEASE. Route: SUBCUTANEOUS
Sponsor: VISTAPHARM LLC. Form: SOLUTION. Route: ORAL
Sponsor: SPECGX LLC. Form: TABLET. Route: ORAL
Sponsor: GENUS LIFESCIENCES. Form: CAPSULE. Route: ORAL
Sponsor: GENUS LIFESCIENCES. Form: SOLUTION. Route: ORAL
Sponsor: ZYLA. Form: TABLET. Route: ORAL
Sponsor: INCYTE CORP. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: SEAGEN. Form: INJECTABLE. Route: INJECTION
Sponsor: ASTRAZENECA UK LTD. Form: INJECTABLE. Route: INJECTION
Sponsor: GENENTECH INC. Form: INJECTABLE. Route: INJECTION
Sponsor: AUROBINDO PHARMA LTD. Form: FOR SUSPENSION. Route: ORAL
Sponsor: AUROBINDO PHARMA LTD. Form: FOR SUSPENSION. Route: ORAL
Sponsor: AMGEN INC. Form: TABLET. Route: ORAL
Sponsor: UCB INC. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: ABBVIE. Form: SOLUTION. Route: ORAL
Sponsor: ABBVIE. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ABBVIE. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ELI LILLY AND CO. Form: INJECTABLE. Route: SUBCUTANEOUS
Sponsor: AURINIA. Form: CAPSULE. Route: ORAL
Sponsor: NEUROCRINE. Form: CAPSULE. Route: ORAL
Sponsor: SUN PHARM INDUSTRIES. Form: TABLET. Route: ORAL
Sponsor: WATSON LABS. Form: TABLET. Route: ORAL
Sponsor: PFIZER INC. Form: INJECTABLE. Route: INJECTION
Sponsor: BOEHRINGER INGELHEIM. Form: INJECTABLE. Route: INJECTION
Sponsor: STRIDES PHARMA INTL. Form: FOR SUSPENSION. Route: ORAL
Sponsor: AUROBINDO PHARMA LTD. Form: FOR SUSPENSION. Route: ORAL
Sponsor: HIKMA PHARMS. Form: FOR SUSPENSION. Route: ORAL
Sponsor: HIKMA PHARMS. Form: FOR SUSPENSION. Route: ORAL
Sponsor: HIKMA PHARMS. Form: FOR SUSPENSION. Route: ORAL
Sponsor: AUROLIFE PHARMA LLC. Form: TABLET. Route: ORAL
Sponsor: AUROLIFE PHARMA LLC. Form: TABLET. Route: ORAL
Sponsor: AUROLIFE PHARMA LLC. Form: TABLET. Route: ORAL
Sponsor: AUROLIFE PHARMA LLC. Form: TABLET. Route: ORAL
Sponsor: ISTITUTO BIO ITA SPA. Form: INJECTABLE. Route: INJECTION